Cargando…
Role of Leukotrienes and Leukotriene Modifiers in Asthma
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB(4), are potent lipid mediators that are pivotal in the pathophysiology of asthma phenotypes. At least two receptor subtypes for CysLTs – CysLT(1) and CysLT(2) – have been identified. Most of the pathophysiological effects of CysLTs in asth...
Autor principal: | Montuschi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033953/ https://www.ncbi.nlm.nih.gov/pubmed/27713330 http://dx.doi.org/10.3390/ph3061792 |
Ejemplares similares
-
Asthma control in adolescents: role of leukotriene inhibitors
por: Giavi, Stavroula, et al.
Publicado: (2010) -
Leukotrienes as Modifiers of Preclinical Atherosclerosis?
por: Riccioni, Graziano, et al.
Publicado: (2012) -
Genome-wide association study of leukotriene modifier response in asthma
por: Dahlin, A, et al.
Publicado: (2016) -
Adipokines and Cysteinyl Leukotrienes in the Pathogenesis of Asthma
por: Coffey, Michael J., et al.
Publicado: (2015) -
Role of Leukotrienes on Protozoan and Helminth Infections
por: Rogerio, Alexandre P., et al.
Publicado: (2012)